Search

everythinglearnresearchcommunity

for

Search:↓

Unwanted facial hair significantly impacts over 40% of women's psychological and social well-being, and various treatment options are available.

Women with PCOS have higher levels of a certain growth factor, which can be reduced by taking metformin.

The research suggests that the ZP4 gene is linked to egg development in women with PCOS but requires more study to understand its role in infertility.

Flutamide works better than finasteride for hirsutism, and combining both is slightly better but not much.

Obese women had more testosterone and less acne, but similar hair growth compared to non-obese women.

Using SVF enriched with PRP in surgery for certain fistulas is effective and safe.

Metformin helps manage diabetes, PCOS, and weight in kids but needs more research for long-term safety.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Women with polycystic ovary syndrome have a higher risk of certain fractures.

Hair loss may indicate higher heart risk and metabolic issues.

Oral isotretinoin for severe acne can change hormone levels but does not significantly affect ovarian function.

Internet and community fair recruitment effectively gathered a diverse group for a menstrual health survey.

Male-pattern baldness is weakly linked to some heart disease risk factors but not a strong indicator for heart disease.

Low-dose anti-androgen drugs and certain drug combinations are effective for hirsutism, and insulin sensitizers show promise, especially for those with polycystic ovarian syndrome.

Azelaic Acid is effective and safe for treating adult female acne, with few side effects.

Type 2 diabetes does not change how metformin works in obese pregnant women, so dosage adjustments are not needed.

Low birthweight and rapid weight gain after birth may increase the risk of developing polycystic ovary syndrome.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

Proscar (finasteride) blocks 5α-reductase in sea urchin ovaries and testes, suggesting potential treatment for androgen-related conditions.

People with polycystic ovary syndrome (PCOS) are more likely to have higher levels of depression and anxiety, but their personality traits are similar to those without PCOS.

NIPT can help detect potential maternal cancer, and GIPXplore can identify immune diseases in pregnancies.

Women with congenital adrenal hyperplasia (CAH) have more sexual function issues than those with polycystic ovary syndrome (PCOS), but physical activity can improve sexual functioning in all women.

Women with PCOS may have a higher risk of respiratory and ear infections due to slower nasal mucociliary clearance.

The conclusion is that PCOS is a common cause of hirsutism in young obese women, and early treatment is important to reduce the risk of metabolic syndrome.

Metformin and thiazolidinediones are similarly effective for PCOS, but metformin is often preferred due to fewer side effects.

Stress, nutritional issues, and chronic diseases can cause hair loss, and nail changes may signal internal diseases; treatment focuses on the underlying cause.

Women with PCOS have lower adiponectin hormone levels and are more likely to have insulin resistance.

Excessive body hair in women can be caused by various conditions and treated with medication like Diane® 35 or androgen blockers.

Forensic DNA phenotyping faces challenges due to inconsistent terminology, limited genetic understanding, and debates over technology and models.